MSMaggie Simpson

Maggie Simpson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maggie Simpson has a total of 268 co-authors. Here are the top co-authors by number of shared publications:

  • Mark R Johnson

    Imperial College London, Chelsea and Westminster Hospital, London, UK

    4 shared publications
  • Aarthi R Mohan

    University Hospitals Bristol NHS Foundation Trust, Bristol, UK

    3 shared publications
  • Aidan P Bolger

    East Midlands Congenital Heart Centre, Glenfield Hospital, University Hospitals of Leciester, Leicester, UK

    3 shared publications
  • Catherine E G Head

    Adult Congenital Heart Disease Service, Guys and St Thomas NHS Foundation Trust, London, UK

    3 shared publications
  • Farah Siddiqui

    Obstetrics, Leicester Royal Infirmary, Leicester, UK

    3 shared publications
  • Giuseppe Rosano

    Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome, Rome, Italy

    3 shared publications

Latest Publications

  • Top Cited Papers

    2026 ESC Guidelines for the management of heart failure

    by Lars Køber, Marianna Adamo, Anne-Christine Ruwald, Daniela Tomasoni, Lisa J Anderson, Charlotte Andersson, Jasper J Brugts, Ovidiu Chioncel, Erwan Donal, Peter Ferdinandy, et al.


  • Open Access

    Heart Failure and Cognitive Impairment: A Narrative Review

    by Izabella Uchmanowicz, Heba Aldossary, Maria Próba, Erik Fung, Kenneth Faulkner, Loreena Hill, Marta Kałużna-Oleksy, Wiktoria Szpek, Julia Maj, Asriel Juvenal Chamos, et al.

    Heart failure (HF) is a major global health burden affecting more than 64 million individuals worldwide, and is associated with substantial morbidity, mortality, and healthcare expenditure. Cognitive impairment (CI) is a prevalent and clinically consequential comorbidity, affecting approximately 40–50% of patients with HF across both reduced and preserved ejection fraction phenotypes. Despite its high prevalence and adverse prognostic implications, CI remains systematically underdiagnosed and insufficiently addressed in routine clinical practice. The pathophysiological mechanisms linking HF and CI are multifactorial and incompletely understood, encompassing cerebral hypoperfusion secondary to reduced cardiac output, systemic neuroinflammation driven by pro-inflammatory cytokines, oxidative stress, neurohumoral dysregulation, and cerebrovascular injury. Shared cardiovascular risk factors, including atrial fibrillation, hypertension, diabetes mellitus, and obesity, further compound the risk of cognitive decline. CI exerts a profound impact on clinical outcomes in HF, independently predicting increased all-cause mortality, higher rates of hospitalisation and 30-day readmission, impaired self-care capacity, and reduced medication adherence. Early and systematic identification is a reasonable clinical priority that may support optimised clinical management and informed shared decision-making. This review synthesises current evidence on the epidemiology, pathophysiology, clinical assessment, prognostic significance, and therapeutic implications of CI in HF, and highlights key controversies and priorities for future research.

  • Prevention of heart failure

    by Massimo Piepoli, Giuseppe Rosano, Ana Abreu, Marianna Adamo, Andrea Attanasio, Ovidiu Chioncel, Alain Cohen-Solal, Gerasimos Filippatos, Eva Gerdts, Andreas Gevaert, et al.

    Heart failure (HF) remains a major cause of morbidity, mortality and costs for the healthcare systems worldwide, despite advances in diagnostic and therapeutic strategies. The enhancement of preventive measures is now a priority, but effective prevention requires a multidisciplinary strategy addressing a broad spectrum of comorbidities and risk factors. It must also consider the changes in the prevailing phenotype of the patients with HF with a lower impact of coronary artery disease and the increasing role of renal and metabolic conditions leading mostly to HF with preserved ejection fraction. Prevention of HF must take into consideration arterial hypertension, chronic kidney disease, diabetes mellitus, sedentary lifestyle, obesity, dyslipidemia, female-specific risk factors, as well as adverse effects of chemotherapy and radiotherapy. Other key factors include infections and the protective role of vaccination, and environmental and socio-economic determinants of health. In 2022, a position paper of the Heart Failure Association and the European Association of Preventive Cardiology of the ESC was published as a complete overview on this topic and as a compendium to the 2021 ESC Guidelines on HF. However, since then, significant evidence has emerged regarding the potential to prevent HF, particularly in the context of metabolic disorders, diabetes and kidney diseases. This scientific statement aims to provide an updated perspective, highlighting the importance of a holistic and tailored approach to managing the multifaceted contributors to this syndrome.


  • European Society of Cardiology updated curriculum for heart failure nurses: developed by the Heart Failure Association, in collaboration with the Association of Cardiovascular Nurses and Allied Professions of the European Society of Cardiology

    by Ekaterini Lambrinou, Maggie Simpson, Michela Barisone, Loreena Hill, Camilla Hage, Quin Denfeld, Rodolfo Pike, Wilfried Mullens, Marianna Adamo, Gerasimos Filippatos, et al.

    The role of the nurse in the heart failure (HF) multi-disciplinary team (MDT) has become well-established, with clear evidence of improved patient outcomes and recommended by professional guidelines. Recognizing the change in the HF landscape since the publication of the first Heart Failure Association (HFA) of the European Society of Cardiology (ESC) HF nurse curriculum in 2016, and the expanding role of HF nurses of in the HF MDT, the HFA in collaboration with the Association of Cardiovascular Nursing and Allied Professions (ACNAP) of the ESC prioritized this update to the curriculum. Standardized training programmes for HF nurses improve the quality of care provided to patients with HF and their caregivers. Recognizing the variability of education background and clinical autonomy across Europe and beyond, this curriculum is designed in a flexible way to be able to be adapted and adjusted based on individual country regulations and forms. Endorsement of this curriculum from national professional bodies or Nursing Councils would ensure uniformity and enhance the profession's contribution to HF care. The updated specialist HF nurse curriculum provides the basis for the advanced level of knowledge, skills and attitudes required for the appropriate expansion of the role of the HF nurse that can be adapted across Europe and beyond, while complying with professional legislation of different healthcare systems and supporting nurses who move between countries.

  • Access to medical care globally for patients with peripartum cardiomyopathy: a clinical consensus statement of the Heart Failure Association of the ESC

    by Karen Sliwa, Charle Viljoen, Julian Hoevelmann, Amina Rakisheva, Hasan Ali Farhan, Albertino Damasceno, Neusa Jessen, Silvana Jovanova, Amam Mbakwem, Maggie Simpson, et al.

    Peripartum cardiomyopathy (PPCM) can be a serious condition, presenting with heart failure with reduced ejection fraction towards the end of pregnancy or in the months following delivery. Less than half of the patients fully recover their cardiac function within 6 months of diagnosis, with substantial regional variation. This clinical consensus statement addresses the global and regional heterogeneity of epidemiological data on PPCM, substantial variation in access to medical care, and the contributing factors to poor adherence, as well as the impact of socioeconomic factors. The scope of this document encompasses contemporary challenges and approaches for the management of women diagnosed with PPCM. We provide a framework of practical aspects of starting disease-specific and guideline-recommended medical therapy, rapid up-titration, and improving adherence. Furthermore, the importance of involving women with a new diagnosis of PPCM in the decision-making processes regarding various therapeutic options is highlighted, as this also affects the mental health and quality of life for the patient, as well as for the extended family.


  • Nurses and allied professionals’ engagement in clinical research-in-practice: a statement of the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology

    by Suzanne Fredericks, Julie Sanders, Maria Back, Lien Desteghe, Ana Gomes, Elena Marques-Sule, Maggie Simpson, Jeroen M Hendriks

    Many nurses and allied professionals (NAPs) lack the skills, knowledge and confidence to engage in conducting and implementing research. This statement describes the importance of NAPs' involvement in clinical research within the context of cardiovascular care. The existing gaps, barriers and enablers to NAPs involvement in research as a potential response to workforce issues in these professions as well as to contribute to excellence in patient care delivery and associated outcomes are identified. Specifically, career development pathways for NAPs are discussed. Finally, potential future directions for NAP research in clinical practice are provided.


  • Open Access

    Examining the Clinical Role and Educational Preparation of Heart Failure Nurses Across Europe. A Survey of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) of the ESC

    by Loreena Hill, Nicolas Girerd, Teresa Castiello, Tiny Jaarsma, Marco Metra, Giuseppe Rosano, Patrick Savage, Mark J. Schuuring, Maggie Simpson, Izabella Uchmanowicz, et al.

    Aims: To describe the clinical practice and educational preparation of heart failure (HF) nurses across Europe and determine the key differences between countries. Methods and results: A survey tool was developed, in English, by the Heart Failure Association Patient Care committee of the European Society of Cardiology (ESC). It was translated into eight languages, before electronically disseminated by nurse ambassadors, presidents of HF national societies and through social media. A total of 837 nurses involved in the daily care of patients with HF from 15 countries completed the survey. Most nurses, 78% (n = 395) worked within a hospital outpatient setting, and 51% (n = 431) had access to a specialized HF multidisciplinary team. Nurses performed a range of activities including patient education to promote self-care, virtual and in-person symptom monitoring. A third had more than 5-year experience in cardiac care and 22% (n = 182) prescribed HF medications. There was a significant correlation between HF nurses that prescribed HF medications and access to a specialist multidisciplinary team (p = 0.04). A small number of nurses, mainly from Belgium, supported invasive monitoring (n = 68, 8%) with 14% (n = 120) of mostly Danish nurses supporting exercise programmes. The majority of nurses surveyed were committed to further academic professional development, with 41% (n = 343) having completed a HF course. Conclusion: The role of the HF nurse varies across Europe, however involvement in patient education, symptom monitoring and follow-up remain core to their practice. In specific activities including the prescribing of HF medications and involvement in invasive monitoring, practice has advanced with collaboration in the multidisciplinary team. Consequently, harmonization of education, training and career pathways are required to standardize HF care aligned with expert guidelines across Europe.


  • Open Access

    Optimizing heart failure services: a focus on patients with heart failure with preserved ejection fraction

    by Leeanne Macklin, Maggie Simpson

    This invited commentary refers to ‘What services are currently provided to people with heart failure with preserved ejection fraction in the UK and what are their components? A protocol for a scoping literature review’, by F. Forsyth et al., https://doi.org/10.1093/eurjcn/zvae119.

  • Preconception counselling in women of reproductive age attending cardiology clinics in Scotland

    by Joanna Osmanska, Alice M Jackson, Joanne Simpson, Carly Adamson, Daniel Doherty, Helene Mamet, Lynsey Moir, Niki L Walker, Duncan Hogg, Maggie Simpson

    Background Guidelines for the management of cardiovascular disease (CVD) recommend preconception risk stratification and counselling in all women of childbearing age. We assessed the provision of preconception counselling (PCC) among women of reproductive age attending general cardiology outpatient clinics over a 12-month period in two large health boards in Scotland. Methods and results Electronic health records were reviewed and data on patient demographics, cardiac diagnoses, medication use and the content of documented discussions regarding PCC were recorded. Women were classified according to the modified WHO (mWHO) risk stratification system. Among 1650 women with a cardiac diagnosis included (1 January 2016–31 December 2016), the mean age was 32.7±8.6 years, and 1574 (95.4%) attended a consultant-led clinic. A quarter (402, 24.4%) were prescribed at least one potentially fetotoxic cardiovascular medication. PCC was documented in 10.3% of women who were not pregnant or were unable to conceive at the time of review (159/1548). The distribution of mWHO classification, and proportion of patients within each mWHO category who received any form of PCC, was 15.0% and 6.0% in mWHO class I, 20.2% and 8.7% in mWHO class II, 22.6% and 10.6% in mWHO class II–III, 9.5% and 15.7% in mWHO class III and 3.9% and 19.7% in mWHO class IV. Conclusion PCC is documented infrequently in women of reproductive age with CVD in the general outpatient setting. Education relating to the risks of cardiac disease in pregnancy for clinicians and patients, and tools to support healthcare providers in delivering PCC, is important.